Canonical DCs, comprised of cDC1, CD5− and CD5+ cDC2, pDC, and AS DC, with specialized functions and roles in immunity, have yet to be fully examined within a cohort of CLL patients with diverse disease characteristics. Here, PDC is linked to B-cell chronic lymphocytic leukemia.